Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600117306) titled 'The Effect of Esketamine Combined with Sufentanil Intravenous Patient-Controlled Analgesia on Postoperative Negative Emotions and Recovery Quality in Patients Undergoing Debridement and Skin Grafting' on Jan. 22.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: The First People's Hospital of Lianyungang
Condition:
Burn
Intervention:
Experimental group ES group (esketamine and sufentanil):Esketamine combined with sufentanil
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-02-15
Target Sample Size: Experimental group ES group (esketamine and sufentani...